Drug intelligence / Profile preview

magnesium + eicosapentaenoic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

**Magnesium + eicosapentaenoic acid** is a combination product of two biologically active substances: **magnesium**, an essential mineral involved in neuromuscular function, cardiovascular health, and metabolic processes, and **eicosapentaenoic acid (EPA)**, an omega-3 polyunsaturated fatty acid derived from marine sources. EPA acts primarily as a precursor for less inflammatory eicosanoids and can reduce triglycerides and cardiovascular risk when taken in prescription form (such as icosapent ethyl)[1][2][6]. Magnesium supplementation supports electrolyte balance, cardiac rhythm, muscle contraction, and various enzymatic reactions. This combination is generally found in dietary supplement form, not as an approved pharmaceutical drug. Mechanistically, EPA modulates inflammation, reduces blood vessel constriction, and lowers clotting potential via alteration of eicosanoid signaling[6]. Magnesium supports cardiac electrical stability and metabolic functions.

Other names
magnesium + eicosapentaenoic acid
02

Targets

PPARD (Peroxisome proliferator–activated receptor delta)PPARG (Peroxisome proliferator-activated receptor gamma)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on magnesium + eicosapentaenoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium + eicosapentaenoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call